Chemocentryx Inc Contact Number

Filter Type: All Time (8 Results) Past 24 Hours Past Week Past month Post Your Comments?

Listing Results Chemocentryx Inc Contact Number

(650) 210-2900

Thomas J. Schall, Ph.D. President and Chief Executive Officer . ChemoCentryx, Inc. 850 Maude Avenue Mountain View, CA 94043 (650) 210-2900 (Address, including zip code, and telephone number, including area code, of agent for service) C

Preview / Show more

Updated: just now

See Also: Verify It   Show details

SAN CARLOS, Calif., Nov. 10, 2021 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (NASDAQ:CCXI), today announced that Thomas J. Schall, Ph.D., President and Chief Executive Officer, will participate in two upcoming investor conferences: Stifel 2021 Virtual Healthcare Conference Fireside Chat Wednesday, November 17 at 2:00 p.m. Eastern Time; Piper Sandler 33rd Annual …

Preview / Show more

Updated: 4 hours ago

See Also: Show details

ChemoCentryx, inc (CCXI) Q3 2021 Earnings Call Transcript Nov. 10, 2021 at 1:01 a.m. ET on Motley Fool ChemoCentryx (CCXI) Reports Q3 Loss, Tops Revenue Estimates

Preview / Show more

Updated: 1 hours ago

See Also:Vintage Stock Phone Number, Robinhood Stock Phone Number, Show details

Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result, these ...

Preview / Show more

Updated: 5 hours ago

See Also:Vintage Stock Phone Number, Robinhood Stock Phone Number, Show details

ChemoCentryx, Inc is a biopharmaceutical company engages in the development and commercialization of medicines. It focuses on inflammatory disorders, autoimmune diseases, and cancer. Its drug candidates such as Avacopan and CCX140, selectively blocks a specific chemoattractant receptor, leaving the rest of the immune system intact.

Preview / Show more

Updated: 1 hours ago

See Also: Show details

Using a suite of innovative personality-based products, Mattersight can analyze and predict customer behavior based on the language exchanged during service and sales interactions. This insight can then facilitate real-time connections between customers and the agents best capable of handling their needs.

Preview / Show more

Updated: 2 hours ago

See Also:Capital One Venture Phone Number, Capital Newspapers Contact, Show details

ChemoCentryx launched the drug shortly after receiving approval in the U.S. Tavneos is also approved for use in Japan. The payment it earned for that milestone from its partner Vifor for $20 ...

Preview / Show more

Updated: 5 hours ago

See Also:Motley Fool Phone Numbers, Motley Fool Canada Phone Number, Show details

ChemoCentryx Inc (NASDAQ:CCXI) is the most popular stock in this table. On the other hand Humacyte Inc. (NASDAQ: HUMA ) is the least popular one with only 5 …

Preview / Show more

Updated: 3 hours ago

See Also:Hcc Phone Number, Hcc Fax Number, Show details

All Time (8 Results) Past 24 Hours Past Week Past month

Please leave your comments here:

 

  • Frequently Asked Questions

  • Does chemocentryx have an nda for avacopan?

    MOUNTAIN VIEW, Calif., July 09, 2020 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (NASDAQ: CCXI) today confirmed that the Company has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for avacopan for the treatment of patients with ANCA-associated vasculitis.

  • Who is the CEO of ChemoCentryx?

    ChemoCentryx Inc. (CCXI) reports a wider-than-expected loss in the second quarter and misses on sales. Joining us on the call today is Dr. Thomas Schall, President and Chief Executive Officer of ChemoCentryx, who will review the Company’s recent business and clinical progress.

  • Is ChemoCentryx (CCXI) stock headed for a bad day?

    Investors need to pay close attention to ChemoCentryx (CCXI) stock based on the movements in the options market lately. The latest analyst coverage could presage a bad day for ChemoCentryx, Inc. ( NASDAQ:CCXI ), with the analysts making...

  • When will ChemoCentryx’s second quarter 2021 financial results be released?

    MOUNTAIN VIEW, Calif. , Aug. 02, 2021 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc. , (Nasdaq: CCXI), today announced that the Company’s second quarter 2021 financial results will be released after market close on Monday, August 9, 2021 . ChemoCentryx executive management will host a conference call and

Related Search